Castle Rock Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-17,287
Closed -$2.04M 255
2024
Q3
$2.04M Buy
17,287
+264
+2% +$31.2K 0.49% 54
2024
Q2
$2.48M Buy
17,023
+1,026
+6% +$149K 0.62% 35
2024
Q1
$2.07M Buy
15,997
+4,781
+43% +$618K 0.56% 41
2023
Q4
$1.19M Buy
11,216
+5,224
+87% +$553K 0.36% 75
2023
Q3
$553K Buy
5,992
+794
+15% +$73.2K 0.19% 128
2023
Q2
$416K Buy
+5,198
New +$416K 0.14% 138